|
Sigma Life Science has a wide
variety of tools to answer your
biological questions: Your Favorite Gene - A web research tool with interaction
networks and pathways; RNAi including shRNA and siRNA; Guaranteed Antibodies;
Small Molecules; Zinc Finger Nuclease targeted gene editing; Stem Cell products. Visit
Sigma booth at eBioshow to learn more!
eBioCenter just launched its newly built information portal - eBioPoster, an
open online platform for poster presentation. Scientists are encouraged to
utilize this platform to share their research results globally in scientific
community. Please visitwww.ebioposter.com to
learn more information and view posters.
Headline News
 Aurcana
Corporation Information to Be Available Through Standard & Poor's Market Ac..
Novartis
Corporation Seeks to Buy Rest of Alcon Laboratories, Inc. for $39 Billion
India's
Cipla Ltd. in Drug Supply Talks with GlaxoSmithKline, Teva Pharmaceutical In..
Evolva,
Roche Agree Cancer Drug Research Deal
U.S.
Review of Pfizer Inc. Vaccine Not Completed, Still Has Not Ruled on Prevnar 13
Categorized News
Biochemistry & Biophysics
Researchers
Pin Down Long-elusive Protein That's Essential to 'Life As We Know It'
Vitamin
C 'Cures' Mice With Accelerated Aging Disease
Biodegradable
Particles Can Bypass Mucus, Release Drugs Over Time
New
Insight Into Nerve Cell Communication
Physicist
Sees With "T-Rays"
Featured Experts
Dr.
Clay M. Armstrong Won the Albert Lasker Award for Basic Medical Research in K+
I..
Grant & Funding Opportunities
USDA
Gives Grant to Texas A&M for Corn Genetics
f-star
Raises $11.48M to Advance Antibody-Engineering Engine
Decode
Genetics Gets Another Letter from Nasdaq
Enterprise & Industry
Former
Idera Pharmaceuticals, Inc. CEO at Helm of AesRx, New Startup With Sickle Cel..
Genzyme
Corporation Outsources Certain Processes to Hospira, Inc.
Derma
Sciences, Inc. Signs Three-Year Contract With Leading Global Healthcare Compan..
Investment & Financials
Merck
& Co., Inc.'s Schering-Plough Corporation Wins OK on $165 Million Clarinex Pa..
Paul
Capital Healthcare Commits $100 Million in Initial Funding to Phase III
Develop..
Eli
Lilly up 0.7% on Hiring of Outside Contractors
Swine Flu
U.S.
Encounter With Swine Flu Highlights Health System Weaknesses
Short-Term
School Closures Ineffective For Controlling Influenza Epidemics
ImmuneRegen
BioSciences(R) Reports Additional Positive Results From Study Of Homsper..
| 
